Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.
about
Insights into the antimicrobial properties of hepcidins: advantages and drawbacks as potential therapeutic agentsCharacterization of Virulence-Related Phenotypes in Candida Species of the CUG Clade.Evolution and Application of Inteins in Candida species: A ReviewAre the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their AccuracyEpidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008-2014Antibodies against a β-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients.Current perspective on emergence, diagnosis and drug resistance in Candida aurisInvasive candidiasis in critical care setting, updated recommendations from "Invasive Fungal Infections-Clinical Forum", Iran.Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida aurisAntifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance ProgramMultilocus microsatellite analysis of European and African Candida glabrata isolates.Antifungal Activity of 14-Helical β-Peptides against Planktonic Cells and Biofilms of Candida SpeciesClinical relevance of molecular identification of microorganisms and detection of antimicrobial resistance genes in bloodstream infections of paediatric cancer patientsActivity of Novel Synthetic Peptides against Candida albicans.Candida krusei form mycelia along agar surfaces towards each other and other Candida species.Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study.First description of Candida nivariensis in Brazil: antifungal susceptibility profile and potential virulence attributes.The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrataSpecies Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China.Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit.Robust Extracellular pH Modulation by Candida albicans during Growth in Carboxylic Acids.Epidemiology of Hospitalizations Associated with Invasive Candidiasis, United States, 2002-20121Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis.Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China.Candida Efflux ATPases and Antiporters in Clinical Drug Resistance.Phenotypic and genotypic characteristics of Candida albicans isolates from bloodstream and mucosal infections.Drug resistance mechanisms and their regulation in non-albicans Candida species.Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.Current trends in outwitting resistance development in Candida infections through photodynamic and short peptide therapies: a strategic-shift from conventional antifungal agents.Future therapies targeted towards eliminating Candida biofilms and associated infections.Changing epidemiology of candidaemia in Australia.Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria.Proteomic analysis of hyperadhesive Candida glabrata clinical isolates reveals a core wall proteome and differential incorporation of adhesins.The economic impact of rapid Candida species identification by T2Candida among high-risk patients.In Vitro Interactions of Echinocandins with Triazoles Against Multidrug-Resistant Candida auris.The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).The Role of In Vitro Susceptibility Testing in the Management of Candida and Aspergillus.Microbial epidemiology of candidemia in neonatal and pediatric intensive care units at Children's Medical Center, Tehran.
P2860
Q26991996-6A925F95-B8FE-4D0C-B130-7F10F3A1473AQ27322862-888E596E-AE30-42FF-968E-46749F6E5373Q28078765-974AC709-79CC-47F0-875A-2A4FCAFE4D68Q28084765-95ECDD83-3DD1-4834-B09D-64BE9A995F67Q31032549-886E2805-729C-4D73-9CBC-FE40FBB07C44Q33758772-7CE43AB9-D4A7-458C-8130-3BA800FE601BQ33812143-A4C49C7C-C67C-4950-83B0-F8BDB09217FAQ34452343-C71BB690-D3BF-4770-A6E6-F5C6638F6304Q34492906-6CF19144-9815-4C23-BC8E-7274388F8474Q35746090-E310C6F5-406E-4CDB-B2E7-405CC0A71186Q35903892-DB40B25E-64F5-4261-9E8E-1CC36161820DQ35946831-42237A3D-56D7-40CE-B774-7FD297EC336CQ36105815-9AB0267E-442E-4E60-8C27-BA4156591D6DQ36120361-EEF8F5E3-A868-429B-9A5B-51147CA80987Q36154522-EC4EA947-FA86-49F2-82CF-E2F63055DB78Q36305057-71E08188-1E0A-4B83-9698-A59ED6844956Q36441468-4683A09A-A272-4FA7-A3DE-F3532AB71F7FQ36503873-C5094245-8234-43ED-8105-CFB94ACAB7BFQ36551326-DEBDC48C-BCAC-4509-8AF5-A249F57FAC46Q36930128-8CFF7298-1B2E-490F-B4D7-804E82DECBAEQ37192581-A4FA92B9-213D-4B52-A047-1033FCE7E867Q37417355-5B7C6275-B7C4-4623-A731-0992D5A24883Q37524695-760D378F-0DD2-46CB-BCA6-AE360185DEE2Q37580801-A375A32F-EDDD-4136-8AFA-C1606907A735Q38589279-FA23F6EB-986D-4161-AF44-D02097E18C7DQ38610744-C8C6FF18-C8C6-4C28-9F99-744BF5B879E2Q38684284-FB87C544-6C47-49DA-8B04-5D020A2A09B2Q38702301-CF21D9E3-DD21-4A89-ADDB-EC0D992F9414Q38708362-9A6C4363-0482-41F0-869E-35E9010222C6Q38711698-D055B9E9-5362-453D-B4FF-A74C9AF6B055Q38715450-7BF36248-8F45-43E7-92FE-E3DBC2AB1E44Q38786061-4782B69E-DCEB-46CC-9716-A7BA4CC1323BQ38863487-1F7C6701-7B17-4D6D-A34C-4951EF7A9F79Q38916677-01E8A620-F911-434F-B23B-37B1B884C13DQ38945209-3343E718-929F-4C34-A648-E0437D5266D2Q39020917-F832A44A-697B-43AF-BE52-1D1D49444783Q39092177-B3357316-1EBF-471F-BAB8-D67E49FCF34EQ39375216-29402E95-A59F-4E45-A946-6385F9123BAEQ40045635-FED7CDFB-25B7-4F66-9806-5DFCFDD06A14Q40057634-241269DF-2784-4850-8ED8-E69387761B4A
P2860
Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Epidemiology and outcomes of i ...... apy (PATH) registry 2004-2008.
@ast
Epidemiology and outcomes of i ...... apy (PATH) registry 2004-2008.
@en
type
label
Epidemiology and outcomes of i ...... apy (PATH) registry 2004-2008.
@ast
Epidemiology and outcomes of i ...... apy (PATH) registry 2004-2008.
@en
prefLabel
Epidemiology and outcomes of i ...... apy (PATH) registry 2004-2008.
@ast
Epidemiology and outcomes of i ...... apy (PATH) registry 2004-2008.
@en
P2093
P2860
P921
P1433
P1476
Epidemiology and outcomes of i ...... apy (PATH) registry 2004-2008.
@en
P2093
Annette C Reboli
Billy Franks
Coleman Rotstein
David L Horn
David R Andes
Nkechi E Azie
P2860
P304
P356
10.1371/JOURNAL.PONE.0101510
P407
P577
2014-07-03T00:00:00Z